CIK 0002139097
- Emerging growth company
TRex Bio, Inc.
Sign in to watch- Ticker
- TRXB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-567-5582
- Business address
- C/O TREX BIO, INC., 269 EAST GRAND AVENUE SUITE 300, SOUTH SAN FRANCISCO, CA
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 178,571 shares at $14.00 ($2,499,994)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Conversion Director acquired 41,871 shares (conversion)
- 8-K Event Bylaws or fiscal year change
- 4 Open-market buy 10% owner bought 92,857 shares at $14.00 ($1,299,998)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 2 · 40 filings